Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Iovance Biotherapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IOVA
Nasdaq
8731
https://www.iovance.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Iovance Biotherapeutics Inc
Is Iovance Biotherapeutics Stock a Buy Now?
- Apr 17th, 2024 1:45 pm
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
- Apr 9th, 2024 11:56 am
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
- Apr 8th, 2024 5:51 pm
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
- Apr 5th, 2024 9:03 am
Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?
- Mar 29th, 2024 3:30 pm
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
- Mar 26th, 2024 8:11 am
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies
- Mar 23rd, 2024 1:00 pm
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Mar 22nd, 2024 9:30 pm
Iovance Biotherapeutics (NASDAQ:IOVA) shareholders are still up 122% over 1 year despite pulling back 7.1% in the past week
- Mar 19th, 2024 7:52 pm
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
- Mar 19th, 2024 12:01 am
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
- Mar 18th, 2024 6:00 am
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
- Mar 15th, 2024 12:18 pm
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?
- Mar 7th, 2024 11:01 am
Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst
- Mar 6th, 2024 9:42 am
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
- Mar 5th, 2024 6:00 pm
Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
- Mar 4th, 2024 11:30 am
Could Iovance Biotherapeutics Stock Help You Become a Millionaire?
- Mar 2nd, 2024 11:50 am
Iovance Biotherapeutics to Present at Upcoming Conferences
- Mar 1st, 2024 10:00 pm
Why Iovance Biotherapeutics Stock Got Trounced on Thursday
- Feb 29th, 2024 10:47 pm
Q4 2023 Iovance Biotherapeutics Inc Earnings Call
- Feb 29th, 2024 5:17 pm
Scroll